$1.58
$-0.02 (-1.25%)
End-of-day quote: 04/26/2024
NYSEAM:CATX
Perspective Therapeutics Annual Report
| Year | Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-0.03 | $-0.05 | $-0.08 | $-0.12 | $-0.11 | $-0.09 | $-0.07 | $-0.16 | $-0.12 | $-0.13 | $-0.18 | $-0.27 | $-0.37 | $-0.54 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
141.92m | 87.23m | 67.39m | 67.33m | 55.02m | 55.02m | 55m | 54.87m | 34.58m | 28.98m | 25.79m | 22.93m | 22.93m | 23.09m | |
| OCF | Operating Cash Flow |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | |
| FCF | Free Cash Flow |
|
$0.00M | $0.00M | $0.00M | $-6.05M | $0.00M | $0.00M | $0.00M | $-5.96M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | |
| FCFS | Free Cash Flow Per Share |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
